MARKET

PLSE

PLSE

Pulse Biosciences Inc
NASDAQ
14.67
+0.07
+0.48%
After Hours: 14.67 0 0.00% 16:10 01/06 EST
OPEN
14.47
PREV CLOSE
14.60
HIGH
15.05
LOW
14.45
VOLUME
176.81K
TURNOVER
--
52 WEEK HIGH
25.00
52 WEEK LOW
12.56
MARKET CAP
994.15M
P/E (TTM)
-12.9251
1D
5D
1M
3M
1Y
5Y
1D
Pulse Biosciences Unveils Late-Breaking Data from nPulse Cardiac Catheter Study at AF Symposium
Reuters · 12h ago
Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
Barchart · 18h ago
Weekly Report: what happened at PLSE last week (1229-0102)?
Weekly Report · 1d ago
Pulse Biosciences to Present at J.P. Morgan Healthcare Conference
Reuters · 12/29/2025 21:05
Weekly Report: what happened at PLSE last week (1222-1226)?
Weekly Report · 12/29/2025 10:31
Weekly Report: what happened at PLSE last week (1215-1219)?
Weekly Report · 12/22/2025 10:31
Pulse Biosciences Grants Inducement Stock Options to New Employees
Reuters · 12/19/2025 21:05
PULSE BIOSCIENCES ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 12/19/2025 21:05
More
About PLSE
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s CellFX Nanosecond Pulsed-Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. It is pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation (AF) and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation. Its nsPFA Percutaneous Electrode System consists of a disposable, percutaneous, needle electrode for use with its CellFX Console. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment of AF. The CellFX Console is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. It is also developing a Nanosecond PFA 360-degree Cardiac Catheter System.

Webull offers Pulse Biosciences Inc stock information, including NASDAQ: PLSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLSE stock methods without spending real money on the virtual paper trading platform.